Skip to main content
Urology Case Reports logoLink to Urology Case Reports
. 2022 Nov 30;46:102290. doi: 10.1016/j.eucr.2022.102290

A case of emphysematous pyelonephritis caused by the hypermucoviscosity phenotype of Klebsiellapneumoniae

Yoshihiro Kawaguchi a,∗, Kazuhiro Tada b, Ryoko Shibata b, Hidehiro Ishii c, Naoki Ito d, Tsukasa Igawa d
PMCID: PMC9723515  PMID: 36483448

Abstract

A 70-year-old woman presented to our hospital with 38.2 °C fever. She was diagnosed with high-risk emphysematous pyelonephritis caused by string test-positive Klebsiella pneumoniae and treated with multidisciplinary therapy. The patient developed pyogenic spondylitis during the course of the disease. This is the first reported case of emphysematous pyelonephritis caused by the hypermucoviscosity phenotype of K. pneumoniae and the second reported case of pyogenic spondylitis. The hypermucoviscosity phenotype of K. pneumoniae should be considered as an etiologic agent of emphysematous pyelonephritis.

Keywords: Emphysematous pyelonephritis, Pyogenic spondylitis, String test, Invasive liver abscess syndrome

AbbreviationsAbbreviations: CT, computed tomography

1. Introduction

The hypermucoviscosity phenotype of Klebsiella pneumoniae has been reported frequently in Southeast Asia as a causative agent for invasive liver abscess syndrome that is refractory to liver abscesses. Further, there have been scattered reports of invasive liver abscess syndromes that have not led to liver abscesses.1,2

However, the cause of emphysematous pyelonephritis has not yet been reported. Herein, we report a case of emphysematous pyelonephritis caused by the hypermucoviscosity phenotype of K. pneumoniae.

2. Case presentation

A 70-year-old woman with a history of hypertension and type 2 diabetes presented to our hospital with a chief complaint of fever for 5 days. Her heart rate was 110 beats/min, her respiratory rate was 35 breaths/min, and her body temperature was 38.2 °C. Physical examination revealed left lower back pain. The white blood cell count was 21.8 × 103/μL, platelet count was 5.1 × 104/μL, blood glucose was 818 mg/dL, hemoglobin A1c level was 9.4%, creatinine level was 3.21 mg/dL, and C-reactive protein level was 26.56 mg/dL. Computed tomography (CT) showed extensive air in the perirenal space, and a diagnosis of class 3A emphysematous pyelonephritis was determined (Fig. 1).3 The patient was admitted to the high-care unit and started on meropenem 2 g/day with strict glycemic control. On day 6 after admission, a 10-Fr Malecot catheter (Create medic Co., Ltd Kanagawa, Japan) was inserted into the left renal cortex for drainage. Blood and urine cultures submitted at admission were positive for the string test. Genetic testing revealed magA(−) and rmpA(−). After descaling to cefmetazole sodium (2 g/day), the initially-improving inflammatory findings worsened. On the 9th day after admission, the patient was anuric, and her respiratory condition worsened, resulting in 27 days of continuous hemodiafiltration and 66 days of ventilatory management. As her symptoms worsened, she was treated with meropenem 2 g/day, levofloxacin 500 mg/day, and rifampicin 450 mg/day. Although blood sample data showed improvement, the patient complained of back pain, and on day 39 after admission, a CT scan revealed a new complication of pyogenic spondylitis at L4/5 (Fig. 2). The patient was treated conservatively; a 12-Fr Malecot catheter was inserted on day 47 after admission, replacing the existing catheter, and the Malecot catheter was removed on day 89 after admission. The patient was started on cefazolin 750 mg/day alone on day 97 after admission and was discharged for continued rehabilitation 118 days after admission (Fig. 3).

Fig. 1.

Fig. 1

A simple computed tomography scan reveals air extending to the left perirenal region (arrow).

Fig. 2.

Fig. 2

Soft shadows around the lower lumbar vertebrae were observed, and osteolytic changes in the vertebral endplates appeared, leading to a diagnosis of pyogenic spondylitis.

Fig. 3.

Fig. 3

The graph shows a clinical progress chart.

Changes in antibiotics, treatments, and data such as CRP and WBC are shown.

3. Discussion

We encountered a case of emphysematous pyelonephritis with string test-positive K. pneumoniae as the etiologic agent, which was severely complicated by pyogenic spondylitis.

On the day of admission, urine and blood cultures revealed string test-positive K. pneumoniae. Although Escherichia coli and K. pneumoniae are the most common causative organisms of emphysematous pyelonephritis, no case of string test-positive K. pneumoniae has been reported.4 Genetic testing showed magA(−) and rmpA(−). The patient had thrombocytopenia, acute renal failure, impaired consciousness, and shock, all of which are high-risk factors.3 The patient also did not present with a liver abscess, suggesting that invasive pneumonia may be a subtype of systemic disease, as proposed by Suzuki et al.2

This is the second reported case of pyogenic spondylitis; the first was reported by Suzuki et al.2 Staphylococcus aureus is the most common cause of pyogenic spondylitis.5 In this case, conservative treatment may have led to a hematogenous infection of the spine. It is unclear whether early nephrectomy improves this condition. Invasive liver abscess syndrome has been observed to spread sequentially to other parts of the body, including the lungs, central nervous system, bone and cartilage tissues, and eyes, and this case seems to have followed a similar course.1

In summary, two notable points can be learned from this case. First, string test-positive K. pneumoniae can cause emphysematous pyelonephritis, and second, pyogenic spondylitis can also occur secondary to emphysematous pyelonephritis.

4. Conclusion

Emphysematous pyelonephritis can be caused by string test-positive K. pneumoniae and can also be secondary to pyogenic spondylitis. In addition to imaging and risk assessment, the organisms that cause emphysematous pyelonephritis should also be noted. We hope that more cases are reported in the future, and that a treatment method will be established.

Consent

Written informed consent was obtained from the patient for the publication of this case report.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Data statement

Data are available from the corresponding author upon request.

Declaration of competing interest

None.

Acknowledgements

The author would like to thank Mr. Shinichi Maekawa, Yoshikado Miyagawa, Tetsuya Abe, Kazuya Ura, Naomasa Yoshiyama, and Takaho Tokunaga.

Contributor Information

Yoshihiro Kawaguchi, Email: kawaguchi_yoshihiro@med.kurume-u.ac.jp.

Kazuhiro Tada, Email: ktada@fukuoka-u.ac.jp.

Ryoko Shibata, Email: rouji211@yahoo.co.jp.

Hidehiro Ishii, Email: h-ishii@saiseikai-futsukaichi.org.

Naoki Ito, Email: itou_naoki@med.kurume-u.ac.jp.

Tsukasa Igawa, Email: tigawa@med.kurume-u.ac.jp.

References

  • 1.Siu L.K., Yeh K.M., Lin J.C., Fung C.P., Chang F.Y. Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect Dis. 2012;12:881–887. doi: 10.1016/S1473-3099(12)70205-0. [DOI] [PubMed] [Google Scholar]
  • 2.Suzuki K., Ozaki N., Endo S., et al. Hypermucoviscous invasive Klebsiella pneumoniae syndrome without liver abscess with septic shock and multiple infection: a case report. Nihon Kyukyu Igakukai Zasshi. JAAM. 2020;31(2):53–58. [Google Scholar]
  • 3.Boakes E., Batura D. Deriving a management algorithm for emphysematous pyelonephritis: can we rely on minimally invasive strategies or shood we be opting for earlier nephrectomy? Int Urol Nephrol. 2017;49:2127–2136. doi: 10.1007/s11255-017-1706-8. [DOI] [PubMed] [Google Scholar]
  • 4.Lee C.R., Lee J.H., Park K.S., et al. Antimicrobial resistance of hypervirulent Klebsiella pneumoniae: epidemiology, hypervirulence-associated determinants, and resistance mechanisms. Front Cell Infect Microbiol. 2017;7:483. doi: 10.3389/fcimb.2017.00483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kim N.J. Microbiologic diagnosis of pyogenic spondylitis. Infect Chemother. 2021;53:238–246. doi: 10.3947/ic.2021.0054. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Urology Case Reports are provided here courtesy of Elsevier

RESOURCES